Doctronic logo spinning
Skipping wait room
AI Doctor ready
Starting secure consult

What You Need to Know About Cutaneous Melanoma Staging

Published: Sep 01, 2023

Understanding how doctors stage melanoma can give you insights into treatment options and prognosis. This article breaks down the key points of the TNM staging system for cutaneous melanoma.
Contents

What's the TNM Staging System?

The TNM system is a method used by doctors to describe the size and spread of cancer. 'T' stands for the size of the primary tumor, 'N' indicates if cancer has spread to nearby lymph nodes, and 'M' shows whether it has metastasized to other parts of the body. For melanoma, each of these letters is followed by a number to give more detail about how advanced the cancer is.

Changes in the Latest Edition

The eighth edition of the AJCC staging system introduced a few changes. One of the major updates is the removal of the mitotic rate as a staging criterion for T1 tumors, although it remains an important factor for prognosis. Another change is in how the thickness of the tumor is measured; now it's rounded to the nearest 0.1 mm instead of 0.01 mm.
Cutaneous melanoma is a type of skin cancer characterized by the uncontrolled growth of pigment-producing cells. Understanding its staging is crucial for treatment and prognosis.

Why Staging Matters

Staging helps doctors decide the best treatment plan and determine the prognosis. Different stages correspond to different survival rates and treatment options. For example, early-stage melanoma might only require surgery, while later stages could involve more complex treatments like immunotherapy.

Frequently Asked Questions

Melanoma is staged using the TNM system, which looks at the tumor size, lymph node involvement, and metastasis.

The eighth edition removes mitotic rate as a criterion for T1 tumors and changes how tumor thickness is measured.

Staging helps guide treatment decisions and gives information about survival chances.

'M' stands for metastasis, indicating whether cancer has spread to other parts of the body.

The mitotic rate helps predict how quickly cancer cells are dividing and growing.

Wrapping Up

Understanding melanoma staging can be the key to informed discussions with your healthcare provider.
Want to learn more about your melanoma stage? Get started by consulting Doctronic today!

Related Articles

References

  1. Gershenwald JE, Scolyer RA, Hess KR, et al. Melanoma of the Skin. In: AJCC Cancer Staging Manual: Eighth Edition, Amin MB (Ed), American Joint Committee on Cancer, Chicago 2017. p.563.
  2. Elmore JG, Elder DE, Barnhill RL, et al. Concordance and Reproducibility of Melanoma Staging According to the 7th vs 8th Edition of the AJCC Cancer Staging Manual. JAMA Netw Open 2018; 1.
  3. Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009; 27:6199.

This article has been reviewed for accuracy by one of the licensed medical doctors working for Doctronic. Always discuss health information with your healthcare provider.

AI Doctor Visit Required

Appointments available 24/7

😀 😀 😀
sthetoscope

Top licensed doctors

Available in all 50 states

dossier

Full service care

Prescriptions, referrals & treatment

check

No insurance needed

All notes available in Doctronic

15-min consultation. No hidden costs.

AI Doctor Visit Required
Close icon

Please Chat With Our AI Doctor First

Our AI doctor assessment helps our human doctors prepare for your video visit and provide better care

Lifebuoy

For safety reasons we have been forced to end this consultation.

If you believe this is a medical emergency please call 911 or your local emergency services immediately.

If you are experiencing emotional distress, please call the the Suicide & Crisis Lifeline at 988 or your local crisis services immediately.

Contact us

You can also email us at help@doctronic.ai

We aim to reply within 5-7 days

How likely are you to recommend Doctronic to friends or family?
Not likely at all Extremely likely